Sep 30, 2025 08:10
AXSM - Axsome Therapeutics, Inc
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
125.56 3.93 (3.13%) | --- | --- | --- | 0.0 (0.0%) | 6.07 (4.92%) | --- | 0.0 (0.0%) |
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- -0.97
- Diluted EPS:
- -0.97
- Basic P/E:
- -133.4948
- Diluted P/E:
- -133.4948
- RSI(14) 1m:
- 29.65
- VWAP:
- 129.52
- RVol:
- 1.2857
Events
Period | Kind | Movement | Occurred At |
---|
Related News
Sep 13, 2025 00:12
Aug 27, 2025 11:00
Jun 20, 2025 11:00
Jun 11, 2025 11:00
Jun 05, 2025 07:19
Jun 04, 2025 23:00
May 29, 2025 11:00
May 27, 2025 19:44
May 14, 2025 23:30